Skip to main content
SUSMED, Inc. logo

SUSMED, Inc. — Investor Relations & Filings

Ticker · 4263 ISIN · JP3319150003 T Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 34 across all filing types
Latest filing 2023-09-29 Declaration of Voting R…
Country JP Japan
Listing T 4263

About SUSMED, Inc.

https://www.susmed.co.jp/

SUSMED, Inc. is a research and development-oriented company that promotes digital medicine. The company's business is centered on two main areas: the development of digital therapeutics (DTx), or therapeutic applications, for various diseases such as insomnia, and the provision of clinical development support systems. These systems, which may utilize technologies like blockchain for data management, are designed to improve the efficiency of clinical trials for pharmaceutical development. The company operates under the concept of creating "sustainable medicine" through its technological solutions.

Recent filings

Filing Released Lang Actions
臨時報告書
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a 'Rinji Hokokusho' (Extraordinary Report) filed with the Kanto Local Finance Bureau by SUSMED, Inc. It explicitly details the results of the 8th Annual General Meeting of Shareholders held on September 29, 2023, including the voting results for specific agenda items (articles of incorporation, director appointments, and remuneration). Since the document provides the official results of shareholder votes at a general meeting, it falls under the 'Declaration of Voting Results & Voting Rights Announcements' category.
2023-09-29 Japanese
内部統制報告書－第8期(2022/07/01－2023/06/30)
Regulatory Filings
2023-09-29 Japanese
確認書
Regulatory Filings
2023-09-29 Japanese
有価証券報告書－第8期(2022/07/01－2023/06/30)
Annual Report
2023-09-29 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act in Japan. It serves as a formal certification by the CEO regarding the accuracy of the quarterly report (Quarterly Report/IR). Since this is a specific regulatory filing required to accompany financial reports and does not fit into the other specific categories like 10-K or IR, it is classified as a Regulatory Filing (RNS).
2023-05-12 Japanese
四半期報告書－第8期第3四半期(2023/01/01－2023/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed by SUSMED, Inc. with the Kanto Local Finance Bureau in Japan. It contains detailed financial statements, including the balance sheet and income statement, for the third quarter of the fiscal year ending 2023. As it is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial data, it is classified as an Interim/Quarterly Report. 9M 2023
2023-05-12 Japanese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.